Appili Therapeutics Inc. (APLI.TO)

CAD 0.04

(16.67%)

Total Assets Summary of Appili Therapeutics Inc.

Appili Therapeutics Inc.'s latest annual total assets in 2023 was 1.49 Million CAD , down -52.42% from previous year.
Appili Therapeutics Inc.'s latest quarterly total assets in 2024 Q1 was 2.23 Million CAD , up 49.83% from previous quarter.
Appili Therapeutics Inc. reported annual total assets of 3.13 Million CAD in 2022, down -62.18% from previous year.
Appili Therapeutics Inc. reported annual total assets of 8.28 Million CAD in 2021, down -54.79% from previous year.
Appili Therapeutics Inc. reported quarterly total assets of 1.49 Million CAD for 2023 Q4, down -24.28% from previous quarter.
Appili Therapeutics Inc. reported quarterly total assets of 1.95 Million CAD for 2023 Q2, down -9.79% from previous quarter.

Annual Total Assets Chart of Appili Therapeutics Inc. (2023 - 2016)

Historical Annual Total Assets of Appili Therapeutics Inc. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	1.49 Million CAD	-52.42%
2022	3.13 Million CAD	-62.18%
2021	8.28 Million CAD	-54.79%
2020	18.31 Million CAD	63.93%
2019	11.17 Million CAD	63.48%
2018	6.83 Million CAD	-4.95%
2017	7.19 Million CAD	180.06%
2016	2.56 Million CAD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	2.23 Million CAD	49.83%
2023 Q4	1.49 Million CAD	-24.28%
2023 Q2	1.95 Million CAD	-9.79%
2023 Q1	2.17 Million CAD	-30.7%
2023 Q3	1.96 Million CAD	0.53%
2023 FY	1.49 Million CAD	-52.42%
2022 FY	3.13 Million CAD	-62.18%
2022 Q2	3.9 Million CAD	-45.26%
2022 Q3	2.58 Million CAD	-33.75%
2022 Q4	3.13 Million CAD	21.04%
2022 Q1	7.13 Million CAD	-13.83%
2021 Q1	11.9 Million CAD	-35.01%
2021 FY	8.28 Million CAD	-54.79%
2021 Q4	8.28 Million CAD	-27.11%
2021 Q3	11.36 Million CAD	-4.46%
2021 Q2	11.89 Million CAD	-0.1%
2020 Q4	18.31 Million CAD	-14.94%
2020 Q3	21.53 Million CAD	-9.22%
2020 Q1	26.22 Million CAD	134.66%
2020 FY	18.31 Million CAD	63.93%
2020 Q2	23.72 Million CAD	-9.53%
2019 Q2	3.78 Million CAD	-26.55%
2019 Q1	5.15 Million CAD	-24.55%
2019 FY	11.17 Million CAD	63.48%
2019 Q4	11.17 Million CAD	265.3%
2019 Q3	3.05 Million CAD	-19.24%
2018 Q4	6.83 Million CAD	12.77%
2018 FY	6.83 Million CAD	-4.95%
2018 Q3	6.06 Million CAD	0.0%
2018 Q1	- CAD	-100.0%
2017 Q4	7.19 Million CAD	0.0%
2017 FY	7.19 Million CAD	180.06%
2016 FY	2.56 Million CAD	0.0%

Peer Total Assets Comparison of Appili Therapeutics Inc.

Name	Total Assets	Total Assets Difference
Eupraxia Pharmaceuticals Inc.	26.72 Million CAD	94.423%
Helix BioPharma Corp.	1.48 Million CAD	-0.094%
Microbix Biosystems Inc.	35.65 Million CAD	95.82%
Medicenna Therapeutics Corp.	19.13 Million CAD	92.211%
Satellos Bioscience Inc.	44.29 Million CAD	96.636%
Oncolytics Biotech Inc.	38.82 Million CAD	96.161%
Sernova Corp.	22.1 Million CAD	93.258%